Pharmacogenetics in type 2 diabetes: potential implications for clinical practice.Published in:Genome Medicine, 2011, v. 3, n. 11, p. 76, doi. 10.1186/gm292By:Huang, Chunmei;Florez, Jose C.Publication type:Article
Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing.Published in:2011Publication type:Proceeding
Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine.Published in:Genome Medicine, 2011, v. 3, n. 11, p. 291, doi. 10.1186/gm291Publication type:Article
Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression.Published in:Genome Medicine, 2011, v. 3, n. 11, p. 77, doi. 10.1186/gm293Publication type:Article